Relief for New York City’s Restaurants Offers Little Comfort for the Future


On March 22, New York State’s PAUSE order went into effect, shuttering non-essential businesses statewide, cancelling “non-essential gatherings,” and urging individuals to limit travel and recreational activities.  This order will remain in effect until at least May 28 (and likely extend further) for regions that have not yet met the initial metrics required to enter phase one of the State’s reopening plan.  This includes New York City, where a two-month closure of dining rooms has had a particularly devastating effect on the city’s restaurant industry.

In April, a survey conducted by the National Restaurant Association predicted that the restaurant industry would lose over $80 billion in sales due to COVID-related restrictions.  In New York City, this impact has been keenly felt in the permanent closure of landmark eateries, and the bankruptcy of major chains. Even if New York City is able to begin reopening in June, as predicted by Mayor Bill DeBlasio, dining rooms will be among the last businesses to reopen under New York State’s phased plan.

To address this impact, Mayor DeBlasio this week signed into law seven new measures designed to provide relief for tenants, businesses and, particularly, restaurants.  For food services in particular, these new laws included various limits on charges imposed by third-party delivery services, and extends a moratorium on collection of café fees.  “Our city’s restaurants are struggling during these challenging times,” said Lorelei Salas, Commissioner of the NYC Department of Consumer and Worker Protection. “We are proud to provide some relief so they can operate their open-air cafes without the usual fees and to protect them from high fees as they continue to deliver food to us.”

While such measures no doubt provide some measure of comfort for the City’s burdened restaurant industry, it is by no means clear what the post-pandemic market will offer these businesses.  A recent survey by the James Beard Foundation found that only one in five restaurants were confident of surviving the pandemic closures.  And of course, reopening requires a public willing to eat out again.  With social-distancing requirements likely to remain in effect even after reopening, even the dining experience itself will change.  IT remains to be seen whether the industry, and public, can adapt.
 

About Faruqi & Faruqi, LLP

Faruqi & Faruqi, LLP focuses on complex civil litigation, including securities, antitrust, wage and hour and consumer class actions as well as shareholder derivative and merger and transactional litigation. The firm is headquartered in New York, and maintains offices in California, Georgia and Pennsylvania.

Since its founding in 1995, Faruqi & Faruqi, LLP has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, direct purchasers, consumers and employees.

To schedule a free consultation with our attorneys and to learn more about your legal rights, call our offices today at (877) 247-4292 or (212) 983-9330.

About Adam Steinfeld

Adam Steinfeld is a Partner in Faruqi & Faruqi, LLP's New York office. He practices in the area of antitrust litigation with a focus on competition in the pharmaceutical industry. Mr. Steinfeld has litigated successfully with significant contributions in In re Buspirone Patent & Antitrust Litigation, MDL No. 1410 (S.D.N.Y.) ($220M settlement); In re Cardizem CD Antitrust Litigation, No. 99-MD-1278 (E.D. Mich.) ($110M settlement); In re Relafen Antitrust Litigation, No. 01-12239 (D. Mass.) ($175M settlement); In re Remeron Direct Purchaser Antitrust Litigation, No. 03-cv-0085 (D.N.J.) ($75M settlement); In re Terazosin Hydrochloride Antitrust Litigation, No. 99-MDL-1317 (S.D. Fla.) ($72.5M settlement); In re Tricor Direct Purchaser Antitrust Litig., No. 05-340 (D. Del.) ($250M settlement); and Mylan Pharms., Inc. v. Warner Chilcott, No. 12-cv-3824 (E.D. Pa.) ($12 million settlement).

Tags: faruqi & faruqi, investigation, news, litigation, settlement notice, case, faruqi law, faruqi blog, faruqilaw, Adam Steinfeld, antitrust litigation Adam Steinfeld Adam Steinfeld
Partner at Faruqi & Faruqi, LLP

New York office
Tel: (212) 983-9330
Fax: (212) 983-9331
E-mail: asteinfeld@faruqilaw.com
Social: LinkedIn

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

1901 Avenue of the Stars Suite 1060
Los Angeles, California 90067
(424) 256-2884
(424) 256-2885

Georgia

3565 Piedmont Road NE Building Four, Suite 380
Atlanta, Georgia 30305
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania